An analysis of AAN's evidence-based guideline for IVIg use in neurologic disorders: Provider impact and payer perspectives. (Record no. 28085677)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 00819 a2200205 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517201738.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | ####s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 2163-0402 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1212/CPJ.0b013e31825a77ca |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Satya-Murti, Saty |
245 00 - TITLE STATEMENT | |
Title | An analysis of AAN's evidence-based guideline for IVIg use in neurologic disorders: Provider impact and payer perspectives. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Neurology. Clinical practice |
Date of publication, distribution, etc. | Jun 2012 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 134-138 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Shepard, Katie M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kaufman, Joel M |
773 0# - HOST ITEM ENTRY | |
Title | Neurology. Clinical practice |
Related parts | vol. 2 |
-- | no. 2 |
-- | p. 134-138 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1212/CPJ.0b013e31825a77ca">https://doi.org/10.1212/CPJ.0b013e31825a77ca</a> |
Public note | Available from publisher's website |
No items available.